Ayman Alsebaey
7PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jul 28, 2021
MELD-Sarcopenia is Better than ALBI and MELD Score in Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation.Ayman Alsebaey, Aliaa Sabry, Hanaa Said Rashed
|May 28, 2021
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients.Fatma Omar Khalil, Ayman Alsebaey, Zeinab Abdelaziz Kasemy
|Dec 14, 2020
Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients.Eman Abdelsameea, Ayman Alsebaey, Mohamed Abdel-Samiee
|Nov 28, 2020
Baseline Sarcopenia is Associated with Lack of Response to Therapy, Liver Decompensation and High Mortality in Hepatocellular Carcinoma Patients.Hanaa Badran, Maha Mohammad Elsabaawy, Amr Ragab
|Aug 09, 2019
HCV treatment with direct acting antivirals improves the insulin sensitivity.Ayman Alsebaey, Mostafa Elhelbawy, Wael Abdel-Razek
|Jul 13, 2019
Insulin resistance is not a risk factor for oesophageal varices development in hepatitis C.Ayman Alsebaey, Mostafa Elhelbawy
Pageof 2
Frequent Collaborators
1 joint publications
Eman Abdelsameea
1 joint publications
Mohamed Abdel-Samiee
1 joint publications
Wael Abdel-Razek
1 joint publications
Imam Waked
1 joint publications
Fatma Omar Khalil
1 joint publications
Zeinab Abdelaziz Kasemy
1 joint publications
Shimaa Abdelsattar
1 joint publications
Hanaa Said Rashed
1 joint publications
Maha Mohammad Elsabaawy
